Horm Metab Res 1998; 30(8): 518-522
DOI: 10.1055/s-2007-978924
Originals Clinical

© Georg Thieme Verlag Stuttgart · New York

Effects of Rat Amylin on Renal Function in the Rat

W. Vine, P. Smith, R. LaChappell, E. Blase, A. Young
  • Amylin Pharmaceuticals Inc., San Diego, CA, USA
Weitere Informationen

Publikationsverlauf

1997

1998

Publikationsdatum:
20. April 2007 (online)

Amylin is a peptide secreted from the pancreatic β-cell along with insulin in response to nutrient stimuli. Amylin has been reported to delay gastric emptying, inhibit glucagon secretion and gastric acid secretion, increase plasma lactate, plasma glucose and plasma renin activity, and decrease plasma calcium. Receptors for amylin have been found in the rat nucleus accumbens and the kidney. In the present experiments, amylin was administered to anesthetized rats by continuous intravenous infusions at varied rates. Amylin significantly increased urine flow at an infusion rate resulting in a plasma concentration of ∼ 52 pM, and at a concentration of ∼ 193 pM, it increased sodium excretion, glomerular filtration rate and renal plasma flow. Renal calcium and potassium excretion were significantly elevated at plasma amylin concentrations of ∼ 52 pM and ∼ 193 pM, respectively. Higher concentrations of plasma amylin decreased plasma calcium and potassium and blunted urinary excretion of these electrolytes. Thus, of the renal responses tested, diuresis and natriuresis appeared to be the most sensitive to infused amylin. These renal effects occurred only at plasma concentrations above the normal range, but within the range of concentrations reported in insulin resistant rats.